Загрузка...
Optimizing the use of epidermal growth factor receptor inhibitors in advanced non-small-lung cancer (NSCLC)
Lung cancer is the leading cause of cancer-related death in US and Europe. Treatment with a platinum-based chemotherapy remains the standard of care, however with modest effect on quality of life and overall survival which seldom reaches 1 year. Recently, several classes of targeted agents have emer...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Pioneer Bioscience Publishing Company
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3256492/ https://ncbi.nlm.nih.gov/pubmed/22263061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2010.12.05 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|